Healthcare services after the roll-up era

As platform strategies mature, the advantage shifts from aggregation to integration and operating discipline. For independent owners weighing a partnership, the questions worth asking have changed.

For the better part of a decade, the logic of consolidation in healthcare services was straightforward. Fragmented markets — physician practices, dental groups, therapy clinics, home health, veterinary care, specialty outpatient services — were assembled into regional or national platforms. Scale was expected to bring purchasing leverage, shared administration, better payer conversations and, eventually, a higher valuation for the combined whole than for the parts.

Some of that logic held. Much of it proved harder to realise than the investment memoranda suggested. As the early platforms have matured, a quieter conclusion has emerged across the sector: assembling practices is the easy part. Running them well together is where value is actually made or lost.

For independent owners, that shift matters. It changes what a good partner looks like, what a fair offer should be measured against, and what questions deserve the most time before anything is signed.

From aggregation to integration

In the first phase of a roll-up, growth is largely arithmetic. Each acquisition adds revenue and earnings, and the platform’s reported size rises with every closing. The difficulties tend to arrive later and less visibly: billing systems that never quite merged, clinical protocols that differ from site to site, recruiting that still happens one location at a time, and a central office whose cost grows faster than the efficiencies it was meant to deliver.

A platform that has not integrated is, in practical terms, a holding company for a set of independent practices that happen to share a logo — with an additional layer of overhead and, frequently, a meaningful amount of debt. That structure can work while new acquisitions keep the growth story intact. It becomes fragile when acquisition pace slows, when borrowing costs rise, or when reimbursement pressure compresses margins across the portfolio at once.

The platforms now best positioned are the ones that did the less glamorous work: a single revenue-cycle function that actually performs, consistent scheduling and intake, clinical leadership with real authority, shared data that clinicians trust, and a recruiting engine that makes it easier to attract and keep good people than it would be independently. None of these is a slogan. Each takes years, and each shows up in the day-to-day experience of patients and staff long before it shows up in a set of accounts.

The question is no longer how large a platform has become. It is whether the practices inside it are better run than they were on their own.

What this means for an owner weighing a partnership

An independent owner approached by a platform today is, in effect, being asked to join an operating system. The valuation matters, of course. But the terms around it — and the quality of the organisation behind it — usually determine whether the partnership proves worthwhile over the years that follow. A few considerations tend to deserve more attention than they receive:

  1. Look at the integration, not the map. A long list of locations says little. Ask how many acquired practices are on the same billing, scheduling and reporting systems, how long that took, and what changed for clinicians once it happened. Ask to speak with owners who joined several years ago, not only the most recent additions.
  2. Understand the capital structure. Where a transaction includes rollover equity, the value of that equity depends heavily on how much debt sits above it and on what the platform’s owners expect from their eventual exit. A generous headline figure can be paired with a retained stake that carries considerable risk.
  3. Read the earn-out and employment terms as one document. Deferred consideration tied to future performance is common. It deserves scrutiny alongside the employment agreement, the decision rights you retain and the restrictive covenants, because together they define what you can influence once the business is no longer yours alone.
  4. Ask who decides clinical questions. Governance over scheduling, staffing ratios, referral relationships and protocols is where the cultural fit of a partnership is tested. Ambiguity here is a common source of later friction.
  5. Test the people plan. Your clinicians and managers are the business. A credible partner will have a specific answer about compensation, career paths and how it retains staff through a transition — not a general reassurance.

Each of these touches on legal, regulatory and tax matters that vary by specialty and jurisdiction, and should be worked through with counsel and accountants who know the sector. The aim here is to frame the conversation, not to settle it.

The case for staying independent — and its conditions

The maturing of the platform model does not make partnership the only sensible route. For a well-run independent practice, the alternatives have arguably become more viable, not less. Buyers and partners are more discerning, which means owners who are not under pressure to sell can afford to be discerning too.

Independence works best, however, when it is chosen deliberately rather than by default. The same disciplines that distinguish good platforms — clean revenue-cycle performance, reliable reporting, documented processes, a leadership bench beyond the founding clinicians — also determine whether an independent practice can sustain itself through reimbursement changes, staffing shortages and rising compliance demands. Owners who invest in those disciplines keep their options open. Those who do not often find that the decision to stay independent is quietly made for them, on less favourable terms, at a less convenient moment.

There are also intermediate paths worth considering. Shared-services arrangements, management services organisations, affiliations with larger systems, or a minority investment that funds specific capabilities without transferring control can each address part of what a full partnership offers. None is a universal answer. Each carries its own trade-offs in governance, economics and flexibility, and the right structure depends on what the owner is actually trying to solve.

Preparing either way

Whether an owner ultimately partners, stays independent or chooses something in between, the preparation looks remarkably similar. It begins with an honest picture of the practice as an outsider would see it: how dependent the revenue is on a small number of clinicians or referral sources, how payer mix is likely to shift, how reliable the financial and operational reporting is, and how the business would run if its founders stepped back.

That picture serves two purposes. It strengthens the owner’s hand in any negotiation, because a practice that can evidence its own performance is harder to discount. And it clarifies what the owner wants — which, in our experience, is often less obvious than it first appears. A clinician who wants to reduce administrative burden, one who wants liquidity for retirement, and one who wants capital to expand are asking different questions, and they should be evaluating different kinds of partners.

The roll-up era rewarded speed. What comes next rewards judgement: about which platforms have genuinely built something, about what a fair exchange of independence for support looks like, and about the timing that serves the practice, its people and its patients. Owners who approach those questions early, and with clear eyes, tend to find they have more choices than the market’s noise suggests.

Weighing a partnership offer, or the case for staying independent?

Start a conversation
More perspectives View all